You have access
Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial
MAGDALENA PIRCHER, BRIGITTE MLINERITSCH, MICHAEL A. FRIDRIK, CHRISTIAN DITTRICH, ALOIS LANG, EDGAR PETRU, ANSGAR WELTERMANN, JOSEF THALER, CLEMENS HUFNAGL, SIMON PETER GAMPENRIEDER, GABRIEL RINNERTHALER, SIGRUN RESSLER, HANNO ULMER and RICHARD GREIL
Anticancer Research January 2015, 35 (1) 517-521;